Articles tagged as

Food and Drug Administration

  1. Celgene Vs. Gilead: Vetting for the Best Biopharma

  2. ETF Analysis: Market Vectors Pharmaceutical

  3. 10 Developments By Gilead Sciences That Could Boost Profits

  4. How to Profit from the Generic Drug Trend

  5. How Does Biogen Make its Money?

  6. How NDAs Work and Why They're Important

  7. Could Amgen's Next Drug Be Worth $100 Billion?

  8. 3 Things That Could Hold Intuitive Surgical Back

  9. Did Orexigen Make A Big Mistake?

  10. Are These Biogen Idec's Next Blockbusters?

  11. Why Does Wall Street Hate MannKind?

  12. What’s The Drug That Will Finally Fight Obesity?

  13. Is Ariad On Track To Lose More Shares?

  14. What Is Amgen’s New Target?

  15. Will MannKind Finally Reach A Solid Ground?

  16. What Are The Real Economic Costs Of Obesity?

  17. Gilead Sciences: The New Market-Share Leader

  18. A Checklist For Successful Medical Technology Investment

  19. Getting Started In Stocks

  20. Top 4 Most Scandalous Insider Trading Debacles

  21. 8 Stages Of New Drug Development

  22. Investing In Medical Equipment Companies

  23. Using DCF In Biotech Valuation

  24. Investing In The Biotech Sector

  25. 4 Reasons Why You Love To Hate Big Businesses

  26. Evaluating Pharmaceutical Companies

  27. A Primer On The Biotech Sector

  28. Government Regulations: Do They Help Businesses?

  29. 7 Popular Diet Plans And What They Cost

  30. Baby Boomers Beware: Financial Fraud That Targets Seniors

  31. Scandals That Bring The CEOs Out

  32. Infamous Female Financiers

  33. A Year In Product Recalls

  34. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  35. Investing In The Healthcare Sector

  36. Chasing Down Biotech Zombie Stocks

  37. The Ups And Downs Of Biotechnology

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!